Clinical features and outcomes in high-risk gestational trophoblastic neoplasia
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at the features, outcomes, and factors that affect how well high-risk gestational trophoblastic neoplasia (GTN) patients do. It will review medical records of patients treated at Assiut University Women's Health Hospital to learn more about what predicts success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gestational trophoblastic neoplasia (GTN) that is considered high-risk according to the WHO classification.
- You were treated at Assiut University Women's Health Hospital between January 2020 and December 2025.
- Your medical records include enough information about your diagnosis, pathology, and treatment.
- You do not have a history of other cancers that could confuse the results.
- You are not pregnant at the time of diagnosis, and you do not have a benign molar pregnancy without progression to GTN.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether avelumab (an immune therapy) combined with methotrexate (chemotherapy) can work well as the first treatment for low-risk gestational trophoblastic neoplasia. It aims to improve control of the tumor while keeping side effects acceptable.
This trial is creating a database for women diagnosed with gestational trophoblastic neoplasia (GTN), which includes tumors that can develop after a molar pregnancy or other pregnancy-related conditions. By joining, you help researchers better understand and improve treatment for these rare tumors.
This trial tests a combination of an immunotherapy drug (toripalimab) and a chemotherapy drug (actinomycin-D) as the first treatment for gestational trophoblastic neoplasia (GTN) with a FIGO score of 5-6. It may help patients whose disease is at a moderate risk level.
This trial tests whether using a hysteroscope (a tiny camera) to gently scrape the uterus again, instead of starting chemotherapy right away, can effectively treat a low-risk, pregnancy-related tumor that returns after a molar pregnancy. It's for Chinese women whose disease is still in an early, low-risk stage.
This study looks at the emotional and psychological well-being of women after finishing chemotherapy for gestational trophoblastic neoplasia (GTN). It asks women about their feelings and experiences to better understand and support others going through similar treatment.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
Hear when a new Gestational Trophoblastic Neoplasias (GTN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.